Literature DB >> 11126428

Nutrition, HIV, and drug abuse: the molecular basis of a unique role for selenium.

E W Taylor1, A G Cox, L Zhao, J A Ruzicka, A A Bhat, W Zhang, R G Nadimpalli, R G Dean.   

Abstract

HIV-infected injection drug users (IDUs) often suffer from serious nutritional deficiencies. This is a concern because plasma levels of micronutrients such as vitamin B12, zinc, and selenium have been correlated with mortality risk in HIV-positive populations. Injection drug use also increases lipid peroxidation and other indicators of oxidative stress, which, combined with antioxidant deficiencies, can stimulate HIV-1 replication through activation of NF-kappaB transcription factors, while weakening immune defenses. As detailed herein, these prooxidant stimuli can also increase the pathogenic effects of HIV-1 by another mechanism, involving viral selenoproteins. Overlapping the envelope coding region, HIV-1 encodes a truncated glutathione peroxidase (GPx) gene (see #6 in reference list). Sequence analysis and molecular modeling show that this viral GPx (vGPx) module has highly significant structural similarity to known mammalian GPx, with conservation of the catalytic triad of selenocysteine (Sec), glutamine, and tryptophan. In addition to other functions, HIV-1 vGPx may serve as a negative regulator of proviral transcription, by acting as an NF-kappaB inhibitor (a known property of cellular GPx). Another potential selenoprotein coding function of HIV-1 is associated with the 3' end of the nef gene, which terminates in a conserved UGA (potential Sec) codon in the context of a sequence (Cys-Sec) identical to the C-terminal redox center of thioredoxin reductase, another cellular regulator of NF-kappaB. Thus, in combination with known cellular mechanisms involving Se, viral selenoproteins may represent a unique mechanism by which HIV-1 monitors and exploits an essential micronutrient to optimize its replication relative to the host.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11126428     DOI: 10.1097/00042560-200010001-00009

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  6 in total

1.  Molecular modeling and in vitro activity of an HIV-1-encoded glutathione peroxidase.

Authors:  L Zhao; A G Cox; J A Ruzicka; A A Bhat; W Zhang; E W Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  High rates of serum selenium deficiency among HIV- and HCV-infected and uninfected drug users in Buenos Aires, Argentina.

Authors:  Heidi B Sheehan; Jorge Benetucci; Estela Muzzio; Liliana Redini; Jorge Naveira; Marcela Segura; Mercedes Weissenbacher; Alice M Tang
Journal:  Public Health Nutr       Date:  2011-07-11       Impact factor: 4.022

3.  A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories.

Authors:  B M Berkson
Journal:  Med Klin (Munich)       Date:  1999-10-15

4.  Selenium-Dependent Read Through of the Conserved 3'-Terminal UGA Stop Codon of HIV-1 nef.

Authors:  Lakmini S Premadasa; Gabrielle P Dailey; Jan A Ruzicka; Ethan W Taylor
Journal:  Am J Biopharm Pharm Sci       Date:  2021-11-01

5.  Selenium supplementation at low doses contributes to the decrease in heart damage in experimental Trypanosoma cruzi infection.

Authors:  Andréa P de Souza; Gabriel Melo de Oliveira; Jean Vanderpas; Solange L de Castro; Maria Teresa Rivera; Tania C Araújo-Jorge
Journal:  Parasitol Res       Date:  2003-07-22       Impact factor: 2.289

Review 6.  Cellular Selenoprotein mRNA Tethering via Antisense Interactions with Ebola and HIV-1 mRNAs May Impact Host Selenium Biochemistry.

Authors:  Ethan Will Taylor; Jan A Ruzicka; Lakmini Premadasa; Lijun Zhao
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.